Pfizer Reportedly Manufactures ‘Several Hundred Thousand’ Covid-19 Vaccines Anticipating November Regulatory Approval

The vaccines are ready to be rolled out worldwide should regulators approve it.

Source: Forbes.com Healthcare News - October 19, 2020 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Manufacturing /manufacturing Editors' Pick editors-pick Breaking breaking-news Coronavirus Source Type: news